What do patients' efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry.
Ruth RuscheweyhThomas DreslerStefanie FörderreutherCharly GaulGudrun GoßrauTim Patrick JürgensVictoria RuschilAndreas StraubeJörg ScheidtPublished in: Cephalalgia : an international journal of headache (2023)
In the present population recruited at specialized headache centers, patients rated triptans as more effective than non-opioid analgesics, naproxen as more effective than ibuprofen, and acute medication efficacy decreased with increasing headache frequency.Trial registration: The German Migraine and Headache Society Headache Registry is registered with the German Clinical Trials Register (DRKS 00021081).
Keyphrases
- clinical trial
- end stage renal disease
- newly diagnosed
- liver failure
- healthcare
- ejection fraction
- cross sectional
- prognostic factors
- palliative care
- chronic pain
- patient reported outcomes
- drug induced
- respiratory failure
- electronic health record
- pain management
- open label
- adverse drug
- machine learning
- extracorporeal membrane oxygenation